Content Types: ArticleRegions & Countries: Saudi ArabiaIndustries: Pharma/BiotechMedical & Health
Saudi Arabia has positioned itself as a hub for healthcare and pharmaceutical companies in the GCC region and in recent years, has been providing further regulatory coverage for companies seeking to conduct clinical trials in Saudi Arabia. The Saudi Food and Drug General Authority (“SFDA”) has published guidelines on conducting clinical trials in Saudi Arabia – these include the Guideline for Good Clinical Practice, Regulations and Requirements...
Content Types: ArticleRegions & Countries: Saudi ArabiaIndustries: Information TechnologyServices: Legal
<p> <img src="/uploads/content/images/202203/1647398625_27417.png" alt="" width="600" height="215" title="" align="" /> </p> <p> SDAIA, the Saudi Data & Artificial Intelligence Authority, has just released draft Regulations to the new Personal Data Protection Law, due to come into effect on 23 March 2022. The draft Regulations provide helpful clarity on...
Content Types: EventRegions & Countries: Saudi ArabiaIndustries: Medical & Health
Following on from the successful Arab Health Conference & Exhibition 2022, join us for a virtual panel discussion on Thursday 24 February in collaboration with Bevan Brittan, Healthcare World, KPMG and DIT.
Content Types: ArticleRegions & Countries: Saudi ArabiaIndustries: Information Technology
The Saudi Food & Drug Authority (“SFDA”) recently published guidance on artificial intelligence and ‘Big Data’ in the context of medical devices: Guidance on the Review and Approval of Artificial Intelligence and Big Data based Medical Devices (“AI Guidelines”). The AI Guidelines are to be read in conjunction with the SFDA’s Guidance on Software as a Medical Device.
Although the preferred playing fields of GCC sovereign investment funds have traditionally been Europe and the US, we now see their sands shifting towards China. This momentum shows no signs of abating. What is more, Saudi Arabia is now ready to make its mark on Chinese equity markets, with a strategic approach to purchasing assets.